Biomarin Pharmaceutical Inc (BMRN)
89.53
+0.90
(+1.02%)
USD |
NASDAQ |
Apr 22, 16:00
89.52
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Net Income (TTM): 167.64M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 167.64M |
| September 30, 2023 | 147.02M |
| June 30, 2023 | 99.99M |
| March 31, 2023 | 71.62M |
| December 31, 2022 | 141.56M |
| September 30, 2022 | 83.91M |
| June 30, 2022 | 54.07M |
| March 31, 2022 | 39.35M |
| December 31, 2021 | -64.08M |
| September 30, 2021 | 10.85M |
| June 30, 2021 | 832.14M |
| March 31, 2021 | 790.02M |
| December 31, 2020 | 854.03M |
| September 30, 2020 | 852.02M |
| June 30, 2020 | 122.26M |
| March 31, 2020 | 114.01M |
| December 31, 2019 | -23.85M |
| September 30, 2019 | -42.52M |
| June 30, 2019 | -110.18M |
| March 31, 2019 | -89.54M |
| December 31, 2018 | -77.21M |
| September 30, 2018 | -124.95M |
| June 30, 2018 | -124.86M |
| March 31, 2018 | -144.90M |
| December 31, 2017 | -117.04M |
| Date | Value |
|---|---|
| September 30, 2017 | -156.37M |
| June 30, 2017 | -181.27M |
| March 31, 2017 | -563.45M |
| December 31, 2016 | -630.21M |
| September 30, 2016 | -470.87M |
| June 30, 2016 | -524.37M |
| March 31, 2016 | -187.35M |
| December 31, 2015 | -171.80M |
| September 30, 2015 | -310.21M |
| June 30, 2015 | -211.84M |
| March 31, 2015 | -163.36M |
| December 31, 2014 | -133.97M |
| September 30, 2014 | -126.16M |
| June 30, 2014 | -186.63M |
| March 31, 2014 | -174.66M |
| December 31, 2013 | -176.35M |
| September 30, 2013 | -167.38M |
| June 30, 2013 | -119.71M |
| March 31, 2013 | -130.18M |
| December 31, 2012 | -114.35M |
| September 30, 2012 | -88.07M |
| June 30, 2012 | -100.37M |
| March 31, 2012 | -73.44M |
| December 31, 2011 | -53.84M |
| September 30, 2011 | -39.29M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-110.18M
Minimum
Jun 2019
854.03M
Maximum
Dec 2020
217.89M
Average
99.99M
Median
Jun 2023
Net Income (TTM) Benchmarks
| Eli Lilly and Co | 5.240B |
| Merck & Co Inc | 365.00M |
| Pfizer Inc | 2.119B |
| Bristol-Myers Squibb Co | 8.025B |
| Moderna Inc | -4.714B |